Dendreon to seek Provenge approval in November - Reuters

Dendreon to seek Provenge approval in NovemberReutersNEW YORK, Sept 24 (Reuters) - Dendreon Corp (DNDN.O) plans to seek US approval for its closely watched Provenge prostate cancer vaccine in November and ...Dendreon Expects To File For Provenge Mktg Approval In Mid-NovWall Street JournalDendreon Investor Meeting: Tracking Provenge Like a FedEx PackageTheStreet.comFive Big Questions For Dendreon's Analyst DayXconomySYS-CON Media (press release) -Market Rap -Minyanville.comall 10 news articles »